Views & Reviews Demyelinating Disease After Neurologically

Total Page:16

File Type:pdf, Size:1020Kb

Views & Reviews Demyelinating Disease After Neurologically views & reviews Demyelinating disease after neurologically complicated primary Epstein-Barr virus infection P.F. Bray, MD; K.W. Culp, BS; D.E. McFarlin, MD; H.S. Panitch, MD; R.D. Torkelson, MD; and J.P. Schlight, BS Article abstract-This report describes five patients who, following a neurologically complicated primary Epstein- Barr virus infection, developed progressive or relapsing neurologic deficits. The sequelae in four patients followed 4 to 12 years led to the diagnosis of multiple sclerosis (MS). The fifth patient presented with acute disseminated sclerosis and exhibits diffuse neurologic deficits that have persisted for 2 years. We suggest that the diagnosis of an unexplained acute neurologic or psychiatric syndrome should raise the question of a primary EBV etiology. A precisely timed sero- logic and hematologic study of the blood is imperative to capture the essential evidence. The data presented represent a clinical association between a neurologically complicated primary EBV infection and both chronic and acute demyeli- nating disease. The evidence does not justify a conclusion that EBV virus causes MS. NEUROLOGY 1992;42:278-282 Antibodies to the ubiquitous Epstein-Barr virus The acute neurologic syndromes accompanying (EBV) are in the blood of patients wherever EBV infections take different clinical forms, includ- humans inhabit the planet. Almost all children in ing aseptic meningitis, encephalitis, optic papillitis, the underdeveloped countries are infected, silently cranial neuritis (especially Bell’s palsy), brainstem for the most part, by age 4 years. Until recently, encephalitis, cerebellitis, acute psychosis, severe the virus has maintained a balanced and economic encephalopathy with and without increased relationship with its host. However, in northern intracranial pressure (including Reye’s syndrome), Europe, United States, and Canada, where there is transverse myelitis, postinfectious polyneuritis less overcrowding and better sanitation, about (Guillain-Barre syndrome), brachial neuropathy one-half the population is not infected until the and, rarely, dysautonomia and movement disor- teen years or early adult life, when kissing ders. Although the pathogenesis remains unclear, becomes more habitual and the exchange of saliva almost all parts of the nervous system appear vul- allows the seeding of the uninfected person with nerable to involvement in IM.5-7There have been virus. Approximately one-half of these EBV- repeated descriptions of inflammatory infiltrates seronegative persons develop clinical, heterophile- and diffuse neuronal degenerative changes from positive, infectious mononucleosis (IM), and the brains of fatal cases, and similar pathologic other half experience a clinically unrecognized changes were present in one person convalescing EBV infection. from uncomplicated IM who died secondary to trau- A clinical association between glandular fever or ma.8 The virus has been recovered from CSF in two IM and concurrent acute neurologic complications documented cases of IM-associated encephaliti~,~J~ was documented over 50 years ago,1,2and when but fortunately, most patients with CNS complica- EBV was identified as the causal agent 25 years tions recover fully. late^-,^.^ the same association was ~onfirmed.~-~In Sumaya et all1 were among the first to publish exceptional cases, the disorder can be fatal for dif- serologic data that suggested a relationship ferent systemic reasons or be associated with acute between MS and EBV. Similar studies by us12J3 central or peripheral nervous system syndromes. showed that 100% of MS patients are seropositive Estimates of the frequency of neurologic complica- and that their blood antibody titers to the transfor- tions vary from 1 to 5%.536 mation EBV nuclear antigen (EBNA) and the lytic From the Departments of Neurology and Pediatrics (Dr. Bray, and K.W. Culp and J.P. Schlight), University of Utah, Salt Lake City, UT; the Section on Neuroimmunology (Dr. McFarlin), National Institute of Neurologic Disease and Stroke, NIH, Bethesda, MD; the Department of Neurology (Dr. Panitch), University of Maryland, Baltimore, MD; and the Division of Pediatric Neurology (Dr. Torkelson), University of Nebraska, Omaha, NE. Supported in part by the Clipped Wings (flying personnel, United Airlines), Richard Uriarte, and the Utah Association of Life Underwriters Received May 13, 1991. Accepted for publication in final form July 29, 1991. Address correspondence and reprint requests to Dr. Patrick F. Bray, 50 No. Medical Drive, University Hospital, Salt Lake City, UT 84132 278 NEUROLOGY 42 February 1992 viral capsid antigen (VCA) are significantly elevat- Results. A narrative description of the five ed. patients is given below. Over the past 6 years, we have watched for Patient 1. In 1977, a 30-year-old woman devel- patients with definite laboratory evidence of a pri- oped IM complicated by cerebellitis and brainstem mary EBV infection and in whom other diseases encephalitis. Two positive HA tests were demon- that might mimic a primary EBV infection have strated within 1 month after the onset of her sys- been excluded. Over this observation period, we temic IM symptoms. Over the ensuing 10 months found five patients with laboratory evidence of pri- the disease ran a relapsing-remitting course. CSF mary EBV infection whose courses were complicat- electrophoresis performed after her third relapse ed by acute neurologic syndromes and in whom showed four OCB. An EM1 CT head scan revealed progressive or relapsing neurologic deficits have bilateral frontal lobe white matter lesions. This been observed. patient was reported in abstract form in 1977.20 She was followed and treated in an outpatient MS Methods. The five patients to be reported all exhibited clinic at the National Institutes of Health for 10 hematologic or serologic evidence of a primary EBV years. At age 41 years, her disability had pro- infection, and were included only if an acute neurologic gressed markedly and she was placed in a nursing or psychiatric syndrome was documented, the cause was home. She died at the age of 42 years without otherwise obscure, and neurologic complications persist- autopsy. ed. All patients exhibited CSF evidence of inflammation and quantitative or qualitative immunoglobulin abnor- Patient 2. An ll-year-old girl presented with a malities. Patients with postinfectious polyneuritis were severe acute illness and neurologic findings sug- excluded. gesting brainstem and cerebellar deficits. A serum In making the clinical diagnosis of MS, we adhered to HA test was positive, and CSF examination dis- the standard riter ria.'^^'^ Clinicians have used the terms closed 48 mononuclear cells, a total protein of 38 “remitt i n g- re 1a p s i n g ” and “chronic pro gre s s i v e ” to mg/dl, and OCB on electrophoresis. Bilateral visual describe most cases, but differentiation of these two clini- and brainstem auditory evoked responses were cal types may be difficult and our patients had features abnormal, revealing delayed latencies. For 7 years of both. after the acute illness, she had a relapsing-remit- Three laboratory methods were used to identify a pri- ting course; serial head MRIs showed an increasing mary EBV infection. A standard heterophile antibody (HA) test was used. Manual differential white blood cell number and size of patchy, bilateral, cerebral white counts were performed and special attention was given matter lesions. She is now seriously incapacitated to the presence and percentage of large atypical lympho- and carries the clinical diagnosis of MS. cytes. A complete EBV antibody profile was performed, Patient 3. Within 1 month after making two sui- including an indirect immunofluorescence study of titers cide attempts and being treated with an antide- to VCA (IgG, IgA+IgM), early antibody-diffuse pressant, this 16-year-old girl gradually developed (IgG+IgA), early antibody-restricted (IgG), and EBNA alteration of mood and cognition, and impaired (IgG), and to a negative control. To insure reproducibili- vision. Her first examination revealed bilateral ty, assays were performed in both our laboratory and pyramidal signs, and her CSF exhibited 25 that of Werner and Gertrude HenleI6 at the University of mononuclear cells, increased CNS IgG synthesis, Pennsylvania. Even in patients who exhibit typical clini- cal, hematologic, or HA evidence of primary EBV infec- and OCB in the IgG zone. After treatment for pre- tion, our experience and that of the Henles (personal sumed herpes encephalitis without benefit, she communication) indicate that EBV-specific IgM may be showed progressive deterioration in cognitive func- difficult to demonstrate. This probably results from the tion and diffuse EEG slowing along with a fourfold large molecular size of IgM, which may impede the entry rise in serum anti-EBVCA IgG. A differential of the IgM antibody through the cell membrane, and the leukocyte count at the time of symptom onset difficulty of obtaining commercial fluorescein-labeled showed 12% “atypical lymphocytes.” A brain biopsy IgM that is not contaminated with VCA IgG; the latter performed 2% months after disease onset showed may lead to competition for antigenic binding sites to inflammation and marked loss of myelin, and the IgM molecules within the cell.’? No patient was included pathologist considered the findings most consistent in the study who did not fulfill the serologic or hemato- logic criteria for a primary EBV infection. Other causes with acute MS; an EBV DNA probe study was not for
Recommended publications
  • Vaccination and Demyelination: Is There a Link? Examples with Anti
    Vaccination and demyelination : Is there a link? Examples with anti-hepatitis B and papillomavirus vaccines Julie Mouchet Le Moal To cite this version: Julie Mouchet Le Moal. Vaccination and demyelination : Is there a link? Examples with anti-hepatitis B and papillomavirus vaccines. Human health and pathology. Université de Bordeaux, 2019. English. NNT : 2019BORD0015. tel-02134582 HAL Id: tel-02134582 https://tel.archives-ouvertes.fr/tel-02134582 Submitted on 20 May 2019 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. THÈSE PRÉSENTÉE POUR OBTENIR LE GRADE DE DOCTEUR DE L’UNIVERSITÉ DE BORDEAUX ÉCOLE DOCTORALE : Sociétés, Politique, Santé Publique (SP2) SPÉCIALITÉ : Pharmacologie option Pharmaco-épidémiologie, Pharmacovigilance Par Julie MOUCHET LE MOAL VACCINATION ET RISQUE DE DEMYELINISATION : EXISTE-T-IL UN LIEN ? EXEMPLES DES VACCINS ANTI-HEPATITE B ET ANTI-PAPILLOMAVIRUS Sous la direction de : Monsieur le Professeur Bernard Bégaud Soutenue publiquement le 29 Janvier 2019 Composition du jury Président : Christophe TZOURIO, Professeur des Universités
    [Show full text]
  • Clinical and MRI Clues and Pitfalls in the Diagnosis and Differential Diagnosis of Multiple Sclerosis
    Clinical and MRI clues and pitfalls in the diagnosis and differential diagnosis of Multiple Sclerosis Aksel Siva, M.D. MS Clinic & Department Of Neurology Istanbul University Cerrahpaşa School of Medicine [email protected] MSParis2017 - 7th Joint ECTRIMS - ACTRIMS Meeting, 25 - 28 October 2017 Disclosure • Received research grants to my department from The Scientific and Technological Research Council Of Turkey - Health Sciences Research Grants numbers : 109S070 and 112S052.; and also unrestricted research grants from Merck-Serono and Novartis to our Clinical Neuroimmunology Unit • Honoraria or consultation fees and/or travel and registration coverage for attending several national or international congresses or symposia, from Merck Serono, Biogen Idec/Gen Pharma of Turkey, Novartis, Genzyme, Roche and Teva. • Educational presentations at programmes & symposia prepared by Excemed internationally and at national meetings and symposia sponsored by Bayer- Schering AG; Merck-Serono;. Novartis, Genzyme and Teva-Turkey; Biogen Idec/Gen Pharma of Turkey Introduction… • The incidence and prevalence rates of MS are increasing, so are the number of misdiagnosed cases as MS! • One major source of misdiagnosis is misinterpretation of nonspecific clinical and imaging findings and misapplication of MRI diagnostic criteria resulting in an overdiagnosis of MS! • The differential diagnosis of MS includes the MS spectrum and related disorders that covers subclinical & clinical MS phenotypes, MS variants and inflammatory astrocytopathies, as well as other Ab-associated atypical inflammatory-demyelinating syndromes • There are a number of systemic diseases in which either the clinical or MRI findings or both may mimic MS, which further cause confusion! Related publication *Siva A. Common Clinical and Imaging Conditions Misdiagnosed as Multiple Sclerosis.
    [Show full text]
  • MR Images, Brain Lesions, and Deep Learning
    applied sciences Review MR Images, Brain Lesions, and Deep Learning Darwin Castillo 1,2,3,* , Vasudevan Lakshminarayanan 2,4 and María José Rodríguez-Álvarez 3 1 Departamento de Química y Ciencias Exactas, Sección Fisicoquímica y Matemáticas, Universidad Técnica Particular de Loja, San Cayetano Alto s/n, Loja 11-01-608, Ecuador 2 Theoretical and Experimental Epistemology Lab, School of Optometry and Vision Science, University of Waterloo, Waterloo, ON N2L3G1, Canada; [email protected] 3 Instituto de Instrumentación para Imagen Molecular (i3M) Universitat Politècnica de València—Consejo Superior de Investigaciones Científicas (CSIC), E-46022 Valencia, Spain; [email protected] 4 Departments of Physics, Electrical and Computer Engineering and Systems Design Engineering, University of Waterloo, Waterloo, ON N2L3G1, Canada * Correspondence: [email protected]; Tel.: +593-07-370-1444 (ext. 3204) Featured Application: This review provides a critical review of deep/machine learning algo- rithms used in the identification of ischemic stroke and demyelinating brain diseases. It eval- uates their strengths and weaknesses when applied to real world clinical data. Abstract: Medical brain image analysis is a necessary step in computer-assisted/computer-aided diagnosis (CAD) systems. Advancements in both hardware and software in the past few years have led to improved segmentation and classification of various diseases. In the present work, we review the published literature on systems and algorithms that allow for classification, identification, and detection of white matter hyperintensities (WMHs) of brain magnetic resonance (MR) images, specifically in cases of ischemic stroke and demyelinating diseases. For the selection criteria, we used bibliometric networks. Of a total of 140 documents, we selected 38 articles that deal with the main objectives of this study.
    [Show full text]
  • Demyelination: What Is It and Why Does It Happen?
    Demyelination: What Is It and Why Does It Happen? • Causes • Symptoms • Types • MS and Demyelination • Treatment and Diagnosis • Vaccines • Takeaway What is demyelination? Nerves send and receive messages from every part of your body and process them in your brain. Nerves allow you to speak, see, feel, and think. Many nerves are coated in myelin. Myelin is an insulating material. When it’s worn away or damaged, nerves can deteriorate, causing problems in the brain and throughout the body. Damage to myelin around nerves is called demyelination. Nerves Nerves are made up of neurons. Neurons are composed of a cell body, dendrites, and an axon. The axon sends messages from one neuron to the next. The axon also connects neurons to other cells, such as muscle cells. Some axons are extremely short. Others are 3 feet long. Some axons are covered in myelin. Myelin protects the axons and helps carry axon messages as quickly as possible. Myelin Myelin is made of membrane layers that cover an axon. This is similar to the idea of an electrical wire with coating to protect the metal underneath. Myelin allows a nerve signal to travel faster. In unmyelinated neurons, a signal can travel along the nerves at about 1 meter per second. In a myelinated neuron, the signal can travel 100 meters per second. Certain diseases can damage myelin. Demyelination slows down messages sent along axons and causes the axon to deteriorate. Depending upon the location of the damage, axon loss can cause problems with feeling, moving, seeing, hearing, and thinking clearly. CAUSES Causes of demyelination Inflammation is the most common cause of myelin damage.
    [Show full text]
  • Cerebrospinal Fluid Analysis in Multiple Sclerosis Diagnosis: an Update
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Archivio istituzionale della ricerca - Università di Palermo medicina Review Cerebrospinal Fluid Analysis in Multiple Sclerosis Diagnosis: An Update Bruna Lo Sasso 1, Luisa Agnello 1, Giulia Bivona 1 , Chiara Bellia 1 and Marcello Ciaccio 1,2,* 1 Institute of Clinical Biochemistry, Clinical Molecular Medicine and Laboratory Medicine, Department of Biomedicine, Neuroscience and Advanced Diagnostics, University of Palermo, 90100 Palermo, Italy; [email protected] (B.L.S.); [email protected] (L.A.); [email protected] (G.B.); [email protected] (C.B.) 2 Department Laboratory Medicine, University-Hospital, 90100 Palermo, Italy * Correspondence: [email protected]; Tel.: +39-091-23865701; Fax: +39-091-655-3275 Received: 25 March 2019; Accepted: 30 May 2019; Published: 4 June 2019 Abstract: Multiple sclerosis (MS) is an immune-mediated demyelinating disease of the central nervous system (CNS) with brain neurodegeneration. MS patients present heterogeneous clinical manifestations in which both genetic and environmental factors are involved. The diagnosis is very complex due to the high heterogeneity of the pathophysiology of the disease. The diagnostic criteria have been modified several times over the years. Basically, they include clinical symptoms, presence of typical lesions detected by magnetic resonance imaging (MRI), and laboratory findings. The analysis of cerebrospinal fluid (CSF) allows an evaluation of inflammatory processes circumscribed to the CNS and reflects changes in the immunological pattern due to the progression of the pathology, being fundamental in the diagnosis and monitoring of MS. The detection of the oligoclonal bands (OCBs) in both CSF and serum is recognized as the “gold standard” for laboratory diagnosis of MS, though presents analytical limitations.
    [Show full text]
  • A Case of Balo's Concentric Sclerosis with Typical MRI Findings and Complete Resolution of the Lesion Followi
    A Case of Balo’s Concentric Sclerosis with Typical MRI Findings and Complete Resolution of the Lesion Following Treatment Shitiz K Sriwastava, M.D, Aaron Desai, M.D, Evanthia Bernitsas, MD Department of Neurology, Wayne State University School of Medicine, Detroit, MI INTRODUCTION PATEINT’S CLINCIAL HISTORY RESULTS Balo’s Concentric Sclerosis (BCS) is a rare and severe A year later, following an MS relapse, repeat MRI scan of the After treatment with steroids and plasma exchange, the demyelinating disease of the central nervous system (CNS), brain showed a small enhancing focus at the posterior level of patient’s disease course has been benign with only residual left and it is often viewed as a variant of multiple sclerosis (MS). the Sylvian fissure on the right side, otherwise it was hemiparesis and total resolution of the original Balo‐like lesion. unchanged. The typical lesion in BCS is characterized by concentric layers of demyelination alternating with layers of preserved myelin A follow‐up MRI scan showed total resolution of the original Three years later, the patient experienced a severe relapse and is known as the “onion bulb” appearance. BCS lesion. with new left‐sided weakness and hemiparetic gait. MRI scan It was thought that BCS represents an aggressive MS variant showed classic BCS appearance with alternating hypo and with poor prognosis. hyperintense rings. The patient was treated with IV DISCUSSION However, recent literature contradicts prior observations. We methylprednisolone with some improvement, followed by 6 present a case of BCS with typical MRI findings and complete sessions of plasmapheresis. We present this case of BCS to shed light on this rare subtype resolution of the lesion following treatment.
    [Show full text]
  • (Pre-Allison & Millar) Ipsen Criteria: 1939-48, Boston, MA
    Early criteria (pre-Allison & Millar) Ipsen criteria: 1939-48, Boston, MA USA1 - Probable MS o Those cases with records presenting convincing evidence - Possible MS o Those cases whose evidence was more doubtful. Ipsen acknowledges these allocations are fairly arbitrary but also notes that absolutely certainty of diagnosis is impossible except by autopsy, a limitation we are similarly affected by even today. Westlund & Kurland: 1951, Winnipeg, MT Canada & New Orleans, LA USA2 Diagnostic groupings as follows, with no explicit requirements for each, rather deferring to the discretion of the examining neurologist: - Certain MS - Probable MS - Possible MS o In this class, the changes for and against MS were considered approximately even - Doubtful, unlikely or definitely-not MS2 Sutherland criteria: 1954, Northern Scotland3 - Probable MS o This category for patients in whom the history, the results of clinical examination and, where available, hospital investigations, indicated that the diagnosis of MS was beyond reasonable doubt. - Possible MS o Patients in whom a diagnosis of MS appears justifiable but in which the diagnosis could not be established beyond reasonable doubt; o This group also included patients who did not wish to be examined or could not be seen – review of hospital records for these patients suggested a diagnosis of MS - Rejected cases o Patients found to be suffering from a disease other than MS Allison & Millar Criteria and variants Allison & Millar criteria: 1954, Northern Ireland4 - Early disseminated sclerosis: 1) this category for patients with little in the way of symptomatic presentation but with a recent history consistent with disease onset, i.e. optic neuritis, ophthalmoplegia (double vision), vertigo, sensory problems like pins & needles or numbness, or motor problems like weakness.
    [Show full text]
  • MS & Demyelinating Diseases.Pdf
    JNS-14029; No. of Pages 29 ARTICLE IN PRESS Journal of the Neurological Sciences (2015) xxx–xxx Contents lists available at ScienceDirect Journal of the Neurological Sciences journal homepage: www.elsevier.com/locate/jns MS & Demyelinating Diseases 974 Tehran, Iran; bDepartment of Neurology, Iranian Center of Neurological WFN15-0282 Sciences, Tehran, Iran; cDepartment of Immunology, Tehran University MS & Demyelinating Diseases of Medical Sciences, Tehran, Iran Relationship between HLA-DRB1 genotype and clinical response to interferon-beta among Iranian multiple sclerosis patients Introduction: Multiple sclerosis is the most common autoimmune R. Abolfazlia, S. Samadzadeha, E. Tabibiana, A. Shakoorib, T. Sabokbarc, demyelinating disorder of central nervous system. The role of macro- S.H. Rahimi Dehgolana. aDepartment of Neurology, Tehran University phage in myelin destruction in this disabling disease is undeniable. of Medical Sciences, Tehran, Iran; bDepartment of Medical Genetics Chitotriosidase (Chit) is one of the mammalian enzymes synthesized and fi Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran; secreted by speci cally activated macrophages. Recent studies indicate cNeurology &Neurosciences Research Center, Qom University of Medical that Chit may have a role in the pathogenesis of MS disease. Sciences, Qom, Iran Methods: We analyzed serum obtained from 40 relapsing remitting multiple sclerosis patients and 23 healthy individuals in Iranian Objective: To evaluate the relationship between HLA-DRB1 geno- population. Case and control group were sex and age matched, mean type, which has been proved to be more common in Iranian MS age were 31.92 and 33.54, respectively. In case group, sampling was patients, and clinical response to interferon-beta , which is the most done during attack before receiving steroid pulse or immunomodula- common immunotherapy for RRMS.
    [Show full text]
  • Balo`'S Concentric Sclerosis: Still to Be Considered As a Variant of Multiple Sclerosis?
    Neurol Sci (2015) 36:2277–2280 DOI 10.1007/s10072-015-2297-8 BRIEF COMMUNICATION Balo`’s concentric sclerosis: still to be considered as a variant of multiple sclerosis? Anna M. Pietroboni1 • Andrea Arighi1 • Milena A. De Riz1 • Laura Ghezzi1 • Alberto Calvi1 • Sabrina Avignone2 • Elisa Scola2 • Daniela Galimberti1 • Fabio Triulzi2 • Elio Scarpini1 Received: 26 March 2015 / Accepted: 16 June 2015 / Published online: 25 June 2015 Ó Springer-Verlag Italia 2015 Abstract Balo`’s concentric sclerosis (BCS) is considered a presentation of BCS. Moreover, these case reports suggest that rare demyelinating disease and regarded as an aggressive BCS may neither be rapidly progressive nor fatal and may be variant of multiple sclerosis (MS). We describe three cases considered part of the MS spectrum. In line with this hypoth- (one male and two females) with neuroimaging features sug- esis, current treatments for MS were effective in our patients. gestive of BCS and heterogeneous symptoms, with benign long-term clinical course upon treatment with natalizumab and Keywords Balo`’s concentric sclerosis (BCS) Á Multiple fingolimod. Neurological examination, blood and cere- sclerosis (MS) Á Clinically isolated syndrome (CIS) brospinal fluid analyses, brain and spinal cord magnetic reso- nance imaging (MRI) and brain proton magnetic resonance spectroscopy were performed. At onset, patient #1 showed Introduction predominant cognitive impairment with consciousness distur- bances; patient #2 presented with left hemiparesis; patient #3 Balo`’s concentric sclerosis (BCS) is a rare demyelinating demonstrated hesitance in speech and in written word pro- disease and it is regarded as one of the atypical forms of duction, along with right central facial palsy.
    [Show full text]
  • ADEM) After Autologous Peripheral Blood Stem Cell Transplant for Non-Hodgkin’S Lymphoma
    Bone Marrow Transplantation, (1999) 24, 1351–1354 1999 Stockton Press All rights reserved 0268–3369/99 $15.00 http://www.stockton-press.co.uk/bmt Case report Acute disseminated encephalomyelitis (ADEM) after autologous peripheral blood stem cell transplant for non-Hodgkin’s lymphoma A Re and R Giachetti Department of Hematology, University of Parma, Italy Summary: High-dose chemotherapy followed by autologous periph- eral blood stem cell transplantation (PBSCT) is a thera- Acute disseminated encephalomyelitis (ADEM) is a peutic intervention performed with increasing frequency for demyelinating disorder of the central nervous system hematologic and solid malignancies.4 The widespread use with an acute clinical onset and a wide variability in of this procedure depends on its safety and easy feasibility. severity and outcome. It usually follows a viral infection Mild organ toxicities and low incidence of life-threatening or an immunization and is thought to be immuno- complications are usually reported. Neurologic events are mediated. We report a case of ADEM with a dramatic frequently mild and reversible and usually secondary to clinical onset in an autologous peripheral blood stem injury to other organ systems.5 cell transplant (PBSCT) recipient for non-Hodgkin’s We report a case of ADEM in an autologous PBSCT lymphoma who developed the neurologic syndrome 12 recipient with non-Hodgkin’s lymphoma (NHL) who days after PBSC reinfusion. This is the first report of developed the syndrome on day ϩ12 after PBSC ADEM in the setting of autologous PBSCT, a thera- reinfusion, without any recognizable etiology. To our peutic procedure performed with increasing frequency knowledge, this is the first report of ADEM developing in a wide variety of hematologic and solid malignancies.
    [Show full text]
  • Targeted Complement Inhibition at Synapses Prevents Microglial Synaptic Engulfment and Synapse Loss in Demyelinating Disease
    Article Targeted Complement Inhibition at Synapses Prevents Microglial Synaptic Engulfment and Synapse Loss in Demyelinating Disease Graphical Abstract Authors Sebastian Werneburg, Jonathan Jung, Rejani B. Kunjamma, ..., Brian Popko, Daniel S. Reich, Dorothy P. Schafer Correspondence [email protected] In Brief The mechanisms underlying synaptic changes in multiple sclerosis (MS) remain unclear. Werneburg et al. identify microglia-mediated synapse engulfment and synapse loss in MS patients and multiple MS-relevant animal models. Synapse loss can occur early and prior to other MS-relevant pathology and is associated with synapse-localized complement C3. An AAV approach to inhibit C3 protects synapses and preserves circuit function. Highlights d Microglia engulf and eliminate synapses in the visual thalamus of MS patients d MS-relevant animal models show synapse engulfment and loss occur early in disease d Complement C3, but not C1q, localizes to synapses in demyelinating disease d AAV-Crry inhibits C3 and microglia-mediated synapse loss and preserves function Werneburg et al., 2020, Immunity 52, 167–182 January 14, 2020 ª 2019 Elsevier Inc. https://doi.org/10.1016/j.immuni.2019.12.004 Immunity Article Targeted Complement Inhibition at Synapses Prevents Microglial Synaptic Engulfment and Synapse Loss in Demyelinating Disease Sebastian Werneburg,1 Jonathan Jung,1 Rejani B. Kunjamma,2 Seung-Kwon Ha,3 Nicholas J. Luciano,3 Cory M. Willis,4 Guangping Gao,5,6,7 Natalia P. Biscola,8 Leif.A. Havton,8,9 Stephen J. Crocker,4 Brian Popko,2
    [Show full text]
  • Acute Transverse Myelitis and Acute Disseminated Encephalomyelitis
    Acute Transverse Myelitis and Acute Disseminated Encephalomyelitis Ilana Kahn, MD* *Children’s National Health System, George Washington University Medical School, Washington, DC Education Gap Most pediatricians report lack of knowledge related to the understanding of the diagnosis and treatment of both acute disseminating encephalomyelitis and acute transvers myelitis. Pediatric providers should understand presenting symptoms, initial diagnostic testing, and acute treatment. Clinicians should know when to refer to a neurologist for evaluation of long-term treatment. Objectives After completing this article, readers should be able to: 1. Define and characterize acquired demyelinating syndromes. 2. Identify the prevalence, etiology, and clinical presentations of acute disseminating encephalomyelitis (ADEM) and acute transverse myelitis (ATM). 3. Initiate a diagnostic evaluation, including an evaluation for medical emergencies. 4. Make treatment decisions for acute management. 5. Counsel patients on long-term outcomes after ADEM and ATM. AUTHOR DISCLOSURE Dr Kahn has disclosed 6. Counsel patients on recurrence risks for multiphasic or chronic no financial relationships relevant to this article. This commentary does not contain a demyelinating diseases. discussion of an unapproved/investigative use of a commercial product/device. ABBREVIATIONS INTRODUCTION ADEM acute disseminated encephalomyelitis ADS acquired demyelinating syndrome Acquired demyelinating syndromes (ADSs) encompass a group of immune- AQP4 aquaporin-4 mediated disorders in which there is breakdown of the myelin sheath, the lipid- ATM acute transverse myelitis CNS central nervous system rich covering around the axon that increases conduction speed and metabolic CSF cerebrospinal fluid efficiency of the neuron. ADSs are characterized by a sudden onset of new IgG immunoglobulin G neurologic symptoms in concurrence with neuroimaging evidence of demyelin- IVIg intravenous immunoglobulin MOG myelin oligodendrocyte glycoprotein ation.
    [Show full text]